Assignee
PHARMASCIENCE INC
US·11 granted patents·16 pending applications·445 citations·filing 1998–2019
Top patents by PatentIndex Score
27 records- 0191US6287600B1Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandinPHARMASCIENCE INC·Filed 2000·Granted Sep 11, 2001·69 cites·36 claims
- 0291US6211247B1Administration of resveratrol to prevent or treat restenosis following coronary interventionPHARMASCIENCE INC·Filed 1999·Granted Apr 3, 2001·187 cites·18 claims
- 0387US6022901AAdministration of resveratrol to prevent or treat restenosis following coronary interventionPHARMASCIENCE INC·Filed 1998·Granted Feb 8, 2000·93 cites·15 claims
- 0486US6183779B1Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandinPHARMASCIENCE INC·Filed 1999·Granted Feb 6, 2001·78 cites·35 claims
- 0583US8012944B2Method for treating cancer using IAP antisense oligomer and chemotherapeutic agentPHARMASCIENCE INC·Filed 2004·Granted Sep 6, 2011·15 cites·35 claims
- 0673US9447102B2Protein kinase inhibitorsPHARMASCIENCE INC·Filed 2013·Granted Sep 20, 2016·2 cites·7 claims
- 0768US9822120B2Protein kinase inhibitorsPHARMASCIENCE INC·Filed 2014·Granted Nov 21, 2017·1 cites·21 claims
- 0862US9365614B2IAP BIR domain binding compoundsPHARMASCIENCE INC·Filed 2014·Granted Jun 14, 2016·0 cites·35 claims
- 0959US8765681B2IAP BIR domain binding compoundsPHARMASCIENCE INC·Filed 2012·Granted Jul 1, 2014·0 cites·33 claims
- 1058US2009142398A1Novel pharmaceutical compositions comprising a disintegration matrixPHARMASCIENCE INC·Filed 2008·Application pending·0 cites
- 1156US2007224266A1Descarbonylethoxyloratadine containing pharmaceutical compositionPHARMASCIENCE INC·Filed 2006·Application pending·0 cites
- 1252US2007092565A1Gastric retention drug delivery systemPHARMASCIENCE INC·Filed 2005·Application pending·0 cites
- 1352US2021077413A1Cholestyramine formulations and methods of usePHARMASCIENCE INC·Filed 2019·Application pending·0 cites
- 1450US2018117158A1Abuse Deterrent Pharmaceutical CompositionPHARMASCIENCE INC·Filed 2017·Application pending·0 cites
- 1547US2015110869A1Pharmaceutical composition of entecavir and process of manufacturingPHARMASCIENCE INC·Filed 2013·Application pending·0 cites
- 1646US9795608B2Protein kinase inhibitorsPHARMASCIENCE INC·Filed 2016·Granted Oct 24, 2017·0 cites·8 claims
- 1746US2019076366A1Pharmaceutical composition of entecavir and process of manufacturingPHARMASCIENCE INC·Filed 2018·Application pending·0 cites
- 1845US2017158697A1Protein Kinase InhibitorsPHARMASCIENCE INC·Filed 2014·Application pending·0 cites
- 1945US2016289236A1Protein Kinase InhibitorsPHARMASCIENCE INC·Filed 2014·Application pending·0 cites
- 2044US2014335176A1Disintegrant-free delayed release doxylamine and pyridoxine formulation and process of manufacturingPHARMASCIENCE INC·Filed 2012·Application pending·0 cites
- 2144US2005266075A1Omeprazole dosage formPHARMASCIENCE INC·Filed 2005·Application pending·0 cites
- 2243US2015250886A1Abuse deterrent pharmaceutical compositionPHARMASCIENCE INC·Filed 2013·Application pending·0 cites
- 2342US9796716B2Selective inhibitors of Tec and Src protein kinase familiesPHARMASCIENCE INC·Filed 2013·Granted Oct 24, 2017·0 cites·20 claims
- 2442US2018179210A1Inhibitors of the TEC Kinase Enzyme FamilyPHARMASCIENCE INC·Filed 2016·Application pending·0 cites
- 2542US2011009836A1Pharmaceutical delivery devicePHARMASCIENCE INC·Filed 2008·Application pending·0 cites
- 2637US2016106680A1Abuse Deterrent Immediate Release FormulationPHARMASCIENCE INC·Filed 2014·Application pending·0 cites
- 2730US2017014340A1Orally Disintegrating Tablet of Nabilone Comprising Mannitol-Based GranulesPHARMASCIENCE INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →